Central Pacific Bank Trust Division Neurocrine Biosciences Inc Transaction History
Central Pacific Bank Trust Division
- $723 Billion
- Q1 2025
A detailed history of Central Pacific Bank Trust Division transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Central Pacific Bank Trust Division holds 1,625 shares of NBIX stock, worth $179,725. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,625
Previous 3,702
56.1%
Holding current value
$179,725
Previous $505 Million
64.43%
% of portfolio
0.02%
Previous 0.07%
Shares
5 transactions
Others Institutions Holding NBIX
# of Institutions
656Shares Held
95.2MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.57 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.12 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$541 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$334 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$281 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $10.6B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...